Premium
Microneedles Integrated with Pancreatic Cells and Synthetic Glucose‐Signal Amplifiers for Smart Insulin Delivery
Author(s) -
Ye Yanqi,
Yu Jicheng,
Wang Chao,
Nguyen NhuY,
Walker Glenn M.,
Buse John B.,
Gu Zhen
Publication year - 2016
Publication title -
advanced materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.707
H-Index - 527
eISSN - 1521-4095
pISSN - 0935-9648
DOI - 10.1002/adma.201506025
Subject(s) - materials science , insulin delivery , insulin , signal (programming language) , nanotechnology , amplifier , optoelectronics , medicine , endocrinology , diabetes mellitus , biology , computer science , type 1 diabetes , cmos , programming language
An innovative microneedle (MN)‐based cell therapy is developed for glucose‐responsive regulation of the insulin secretion from exogenous pancreatic β ‐cells without implantation. One MN patch can quickly reduce the blood‐sugar levels (BGLs) of chemically induced type‐1 diabetic mice and stabilize BGLs at a reduced level for over 10 h.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom